Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
49.30
-0.34 (-0.70%)
Feb 12, 2026, 9:56 AM EST - Market open
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $3.02 billion as of February 12, 2026. Its market cap has decreased by -2.88% in one year.
Market Cap
3.02B
Enterprise Value
2.96B
1-Year Change
-2.88%
Ranking
Category
Stock Price
$49.30
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $3.02B, an increase of 711.29%. That is a compound annual growth rate of 33.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.01B | 55.08% |
| Dec 31, 2025 | 1.94B | -29.68% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Charles River Laboratories International | 7.80B |
| ICON Public Limited Company | 5.88B |
| RadNet | 5.39B |
| Sotera Health Company | 4.83B |
| BillionToOne | 4.00B |
| GRAIL | 3.84B |
| Veracyte | 2.79B |
| GeneDx Holdings | 2.74B |